Notably, CD4 T cells with cytolytic signatures and high Eomes expression are found in patients with neuroblastoma, a cancer where CD4 T cells are often more effective than CD8 T cells at promoting tumor destruction [111]. The gene discussed is CD4; the disease is neuroblastoma.